We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Golgi Peptide Can Trigger Apoptosis

By LabMedica International staff writers
Posted on 26 Jan 2009
A team of cellular and molecular biologists have identified a peptide that is the smallest molecule found so far that can trigger the sequence of events leading to apoptosis (programmed cell death).

Investigators at the Albert Einstein College of Medicine (New York City, NY, USA) have been studying the role of intracellular organelles on apoptosis. More...
In the current study, they focused on the Golgi apparatus, the cell's main site for modification and distribution of proteins and other large molecules. The Golgi apparatus is a stack of membrane-bound vesicles that package macromolecules for transport elsewhere in the cell. The enzymatic or hormonal contents of lysosomes, peroxisomes, and secretory vesicles are packaged in membrane-bound vesicles at the periphery of the organelle.

The investigators reported in the January 16, 2009, issue of the Journal of Biological Chemistry (JBC) that a 205 amino acid protein fragment generated by cleavage of the Golgi's p115 protein could be further reduced to a 26 amino acid peptide, which retained the p115 protein's ability to trigger apoptosis. Onset of apoptosis required translocation of the active peptide from the cytoplasm to the nucleus of the cell.

Professor Dennis Shields, who died unexpectedly in December 2008, directed the research effort. "Dennis Shields was one of our most outstanding scientists," said Dr. E. Richard Stanley, chairman of developmental and molecular biology at the Albert Einstein College of Medicine. "His efforts to uncover fundamental mechanisms governing how cells work has led to new ways of thinking about apoptosis, in particular, how the Golgi regulates this process."

Related Links:

Albert Einstein College of Medicine




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.